INSC Activators
INSC activators are chemical entities formulated to enhance the activity of the Inscuteable protein (INSC), which is integral to the correct orientation of cell division, particularly within the context of asymmetric cell division in neuroblasts. This protein plays a crucial role in the spatial arrangement of the mitotic spindle, essential for appropriate cell fate determination and the maintenance of tissue architecture during development. INSC activators might work by promoting INSC's interaction with its cellular partners, stabilizing its active conformation, or facilitating its appropriate subcellular localization. The mechanism of activation could involve direct binding to INSC to promote its function or indirect modulation of signaling pathways that upregulate INSC expression or activity. The enhancement of INSC action by these activators is thus thought to positively influence the fidelity of cell division orientation and the accuracy of cell fate segregation.
Research into INSC activators typically entails sophisticated screening processes to discover molecules that can augment the protein's function. Once identified, these activators undergo rigorous examination to assess their mode of action at the molecular level. Techniques such as affinity-based assays can help quantify the binding between INSC and its activators, while site-directed mutagenesis can be used to determine the specific regions of INSC that are critical for activator interaction. Additionally, the effects of activators on the cellular distribution of INSC can be visualized through immunofluorescence microscopy. To gain a deeper understanding of how INSC activators influence the protein's structure, crystallography or cryo-electron microscopy might be employed to visualize the bound activator within the context of the INSC complex.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid might upregulate INSC by promoting transcriptional activation of genes during the neural differentiation process, where INSC's role is critical for proper cell orientation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may elevate INSC expression by directly stimulating adenylyl cyclase, boosting intracellular cAMP, which then activates protein kinase A (PKA) and the subsequent phosphorylation of transcription factors that could bind to the INSC promoter region. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
This compound may act as a cAMP mimic and stimulate INSC expression by directly activating cAMP-dependent transcription factors, which may enhance the transcription of genes involved in neuroblast division and spindle orientation. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
In engineered systems, tetracycline could be used to induce INSC expression by triggering a tetracycline-responsive promoter that has been artificially linked to the INSC gene, leading to increased transcription in the presence of the antibiotic. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could stimulate the upregulation of INSC by inhibiting the mTOR signaling pathway, which may activate a compensatory transcriptional response to restore cellular homeostasis and growth, potentially involving the INSC gene. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate may stimulate INSC expression by inhibiting histone deacetylases, resulting in an open chromatin configuration and enhanced accessibility of transcription factors to the INSC gene promoter. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could upregulate INSC through the glucocorticoid receptor, which, upon activation, translocates to the nucleus and binds glucocorticoid response elements, potentially increasing the transcription of INSC in neural tissue. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA may stimulate INSC expression by activating protein kinase C (PKC), which can phosphorylate transcription factors or other proteins that control the expression of genes necessary for neural patterning and asymmetry, including INSC. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol could elevate INSC expression by acting on beta-adrenergic receptors, which increase cAMP and activate PKA, leading to the phosphorylation of CREB or other transcription factors that might enhance INSC gene transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A might upregulate INSC expression through its histone deacetylase inhibitory activity, which would relax chromatin around the INSC gene, allowing transcriptional machinery better access to the gene and thus increasing its transcription. | ||||||